In 2023, the global virus filtration market was valued at USD 4.6 billion, driven by factors such as a growing population, increasing demand for biopharmaceutical drugs, and the rising prevalence of chronic diseases. This market is projected to expand at a CAGR of 12.3% from 2024 to 2032, potentially reaching USD 13 billion by the end of the forecast period.